Concepedia

Asahi Ito

AI

Statistics

Publications

46

Citations

1.8K

H-Index

24

Active since

2000

Affiliations

Nagoya City University(Current)

Aichi Medical University

Imamura Hospital

Nagoya University

Nagoya City University Hospital

Asahi Ito is an author at Nagoya City University specializing in oncology, life sciences, and adult t-cell leukemia-lymphoma.

ORCID

Publications per year

2000–2023

46

Publications

46

Bortezomib-resistant myeloma cell lines: a role for mutated PSMB5 in preventing the accumulation of unfolded proteins and fatal ER stress

Masaki Ri, Shinsuke Iida, Takayuki Nakashima et al. · Leukemia · 2010 · 182 citations

, , +17

Identification of Toyocamycin, an agent cytotoxic for multiple myeloma cells, as a potent inhibitor of ER stress-induced XBP1 mRNA splicing

Masaki Ri, Etsu Tashiro, Daisuke Oikawa et al. · Blood Cancer Journal · 2012 · 182 citations · Full text

, , +11

Stevens–Johnson <scp>S</scp>yndrome associated with mogamulizumab treatment of adult <scp>T</scp>‐cell leukemia / lymphoma

Takashi Ishida, Asahi Ito, Fumihiko Sato et al. · Cancer Science · 2013 · 129 citations · Full text

, , +14

Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi-scid, IL-2Rγnull mouse model

Asahi Ito, Takashi Ishida, Hiroki Yano et al. · Cancer Immunology Immunotherapy · 2008 · 127 citations · Full text

, , +16

Cyclin-dependent kinase 9 is a novel specific molecular target in adult T-cell leukemia/lymphoma

Tomoko Narita, Takashi Ishida, Asahi Ito et al. · Blood · 2017 · 69 citations · Full text

, , +13

1–5 of 46